Prediction of Amyloid Fibril-forming Proteins*
暂无分享,去创建一个
[1] P. Y. Chou,et al. Prediction of the secondary structure of proteins from their amino acid sequence. , 2006 .
[2] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[3] J M Ghuysen,et al. 2.8-A Structure of penicillin-sensitive D-alanyl carboxypeptidase-transpeptidase from Streptomyces R61 and complexes with beta-lactams. , 1986, The Journal of biological chemistry.
[4] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Nolde,et al. Three-dimensional structure of proteolytic fragment 163-231 of bacterioopsin determined from nuclear magnetic resonance data in solution. , 1992, European journal of biochemistry.
[6] C. Barrow,et al. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.
[7] R. Huber,et al. Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases , 1992, Nature.
[8] U. Hobohm,et al. Selection of representative protein data sets , 1992, Protein science : a publication of the Protein Society.
[9] L. Hood,et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.
[10] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Rost,et al. Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.
[12] B. Rost,et al. Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.
[13] R. Abagyan,et al. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.
[14] K. Wüthrich,et al. The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. , 1994, Biochemistry.
[15] F. Cohen,et al. Proposed three-dimensional structure for the cellular prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Lippard,et al. Geometry of the soluble methane monooxygenase catalytic diiron center in two oxidation states. , 1995, Chemistry & biology.
[17] K. Wüthrich,et al. Pulmonary surfactant‐associated polypeptide SP‐C in lipid micelles: CD studies of intact SP‐C and NMR secondary structure determination of depalmitoyl‐SP‐C(1–17) , 1995, FEBS letters.
[18] J. Johansson,et al. Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C. , 1995, The Biochemical journal.
[19] L. Tjernberg,et al. Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.
[20] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[21] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[22] R. Wetzel. For Protein Misassembly, It's the “I” Decade , 1996, Cell.
[23] F. Cohen,et al. Physical studies of conformational plasticity in a recombinant prion protein. , 1997, Biochemistry.
[24] F E Cohen,et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[26] J. Cherfils,et al. Structure of the Sec7 domain of the Arf exchange factor ARNO , 1998, Nature.
[27] K. Wüthrich,et al. Pulmonary surfactant‐associated polypeptide C in a mixed organic solvent transforms from a monomeric α‐helical state into insoluble β‐sheet aggregates , 1998, Protein science : a publication of the Protein Society.
[28] I. Kurochkin. Amyloidogenic determinant as a substrate recognition motif of insulin‐degrading enzyme , 1998, FEBS letters.
[29] E. Meyer,et al. Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor α convertase inhibitors , 1998, Protein science : a publication of the Protein Society.
[30] J. W. Kelly. The environmental dependency of protein folding best explains prion and amyloid diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] W. Surewicz,et al. Familial Mutations and the Thermodynamic Stability of the Recombinant Human Prion Protein* , 1998, The Journal of Biological Chemistry.
[32] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Riek,et al. Prion protein structural features indicate possible relations to signal peptidases , 1998, FEBS letters.
[34] J. Johansson,et al. Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. , 1998, European journal of biochemistry.
[35] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[36] J. Thyberg,et al. Amyloid fibril formation by pulmonary surfactant protein C , 1999, FEBS letters.
[37] M. Hecht,et al. De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] Anne Lecroisey,et al. The crystal structure of HasA, a hemophore secreted by Serratia marcescens , 1999, Nature Structural Biology.
[40] P. Lansbury. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Glockshuber,et al. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. , 1999, Biochemistry.
[42] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[43] Lars Terenius,et al. A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.
[44] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[45] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[46] K Wüthrich,et al. NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] K. Davis,et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.